28
Oct
2025

TBD Pharmatech

Exhibitor at CPHI Frankfurt 2025 stand 6.0C2, Contract Manufacturing and Services
About Us

TBD Pharmatech (formerly TBD-Biodiscovery) is a small-molecule fine chemicals CDMO based in Estonia, EU.

TBD has been GMP-compliant since 2008 and certified to ISO 9001:2015

TBD manufactures generics (APIs), innovative compounds, and other custom small-molecules such as excipients, intermediates or impurities tailored for our customers requirements from g to 150kg batch scale. 

Currently, TBD is welcoming partnership projects into our new EU-based GMP facility, set to launch in 2025.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • EE
  • 2015
    On CPHI since
  • 2
    Certificates
  • 50 - 99
    Employees
Company types
CMO/CDMO
Primary activities
Analytical Services
API Producer
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Generic APIs producer
Intermediates Manufacturer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 6.0C2, Contract Manufacturing and Services

Products Featured at CPHI Frankfurt 2025

  • Butorphanol tartrate

    Product Butorphanol tartrate

    Butorphanol tartrate is a synthetic opioid analgesic and is used for the management of moderate to severe pain, as well as for sedation in certain medical procedures.

    It is commonly used in both human and veterinary medicine. In veterinary medicine, it’s often used for pre-anesthetic medicat...